BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15518074)

  • 1. [Contemporary opinions on the clinical symptoms, diagnosis and treatment of primary HIV infection].
    Knysz B; Gasiorowski J; Czarnecki M; Gładysz A
    Wiad Lek; 2004; 57(5-6):267-70. PubMed ID: 15518074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort.
    Ghosn J; Deveau C; Chaix ML; Goujard C; Galimand J; Zitoun Y; Allègre T; Delfraissy JF; Meyer L; Rouzioux C;
    J Antimicrob Chemother; 2010 Apr; 65(4):741-8. PubMed ID: 20167586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary HIV infection: an often suspected diagnosis but confirmed late].
    Galetto-Lacour A; Kinloch-de Loës S; Hirschel B; Perrin L
    Schweiz Med Wochenschr; 1995 Feb; 125(8):341-6. PubMed ID: 7709182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Virological diagnosis of HIV infection in children].
    Muñoz Fernández MA
    Allergol Immunopathol (Madr); 1998; 26(3):122-9. PubMed ID: 9675394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute HIV infection: diagnosis and management in the emergency department.
    Self WH
    Emerg Med Clin North Am; 2010 May; 28(2):381-92, Table of Contents. PubMed ID: 20413020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of anti-R7V antibodies in HIV-infected patients under highly active antiretroviral therapy].
    Ergünay K; Altinbaş A; Calik Başaran N; Unal S; Us D; Karabulut E; Ustaçelebi S
    Mikrobiyol Bul; 2008 Jul; 42(3):413-9. PubMed ID: 18822884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
    Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
    Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical manifestations of HIV infection during seroconversion].
    Kravchenko AV; Iurin OG; Buravtsova EV; Pankova GIu; Serebrovskaia LV; Galina MV; Roslyĭ IM; Pokrovskiĭ VV
    Ter Arkh; 1995; 67(11):24-7. PubMed ID: 8571243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
    Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early identification of seronegative human immunodeficiency virus type 1 infection with severe presentation.
    Chin BS; Lee SH; Kim GJ; Kee MK; Suh SD; Kim SS
    J Clin Microbiol; 2007 May; 45(5):1659-62. PubMed ID: 17344360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.
    Ghosn J; Pellegrin I; Goujard C; Deveau C; Viard JP; Galimand J; Harzic M; Tamalet C; Meyer L; Rouzioux C; Chaix ML;
    AIDS; 2006 Jan; 20(2):159-70. PubMed ID: 16511408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems in the diagnosis of AIDS].
    Matsushita S
    Rinsho Byori; 1994 Dec; 42(12):1248-52. PubMed ID: 7869588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
    Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
    Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What is the patient's HIV status?].
    Christiansen CB
    Ugeskr Laeger; 2000 May; 162(20):2912. PubMed ID: 10860440
    [No Abstract]   [Full Text] [Related]  

  • 17. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.
    Seoane Reula E; Bellon JM; Gurbindo D; Muñoz-Fernandez MA
    Br J Dermatol; 2005 Aug; 153(2):382-9. PubMed ID: 16086754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary human immunodeficiency virus.
    Taiwo BO; Hicks CB
    South Med J; 2002 Nov; 95(11):1312-7. PubMed ID: 12539999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of transmission of drug-resistant HIV on the course of infection and the treatment success. Data from the German HIV-1 Seroconverter Study.
    Poggensee G; Kücherer C; Werning J; Somogyi S; Bieniek B; Dupke S; Jessen H; Hamouda O;
    HIV Med; 2007 Nov; 8(8):511-9. PubMed ID: 17944684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.